Key result
Hypertension rivals diabetes for CKD progression, with both linked to ~77% higher kidney failure risk.
Why the study?
Hypertension and type 2 diabetes are established drivers of CKD progression, but whether one is more strongly associated with progression than the other was unknown.
Is hypertension or type 2 diabetes more strongly associated with CKD progression in patients with chronic kidney disease?
Cohort (n=438,273)
Is hypertension or type 2 diabetes more strongly associated with CKD progression in patients with chronic kidney disease?
Hypertension is associated with an equal or greater risk of CKD progression compared to type 2 diabetes, highlighting the need for aggressive management of both conditions.
Answers are grounded in this paper and cite their sources.
May support equal vigilance for hypertension and diabetes in CKD; observational data leaves causality and targets open.
OBJECTIVES: To evaluate whether between hypertension and type 2 diabetes (T2D)-established drivers of chronic kidney disease (CKD) progression-one might be more strongly associated with CKD progression than the other. DESIGN: Cohort study using a primary care database (electronic health records). SETTING: Primary care in Catalonia, Spain. PARTICIPANTS: 438 273 patients with CKD identified from the Information System for Research in Primary Care database in Catalonia (2007-2017) and stratified into four mutually exclusive groups based on the presence/absence of hypertension and/or T2D. Distribution of the CKD study cohort was as follows: CKD with hypertension (51.1%), CKD with T2D (3.9%), CKD with hypertension and T2D (32.8%), CKD without hypertension and T2D (12.2%). PRIMARY AND SECONDARY OUTCOME MEASURES: ). Subdistributional hazard ratios (sHRs) were estimated using Cox regression adjusted for confounders. RESULTS: Compared with the CKD without hypertension and T2D group, adjusted sHRs (95% CIs) for SKI/kidney failure were 1.77 (1.65 to 1.89) for CKD with hypertension and T2D, 1.50 (1.41 to 1.59) for CKD with hypertension and 1.21 (1.09 to 1.34) for CKD with T2D, and for kidney failure were 1.24 (1.10 to 1.39) for CKD with hypertension, 0.74 (0.61 to 0.90) for CKD with T2D and 1.09 (0.96 to 1.24) for CKD with hypertension and T2D. The strongest risk factors for CKD progression were low eGFR and albuminuria, even at mild-moderate levels. CONCLUSIONS: Hypertension could be associated with an equal/greater risk of CKD progression as T2D. Efforts to slow CKD progression should target both patients with hypertension and T2D, focusing on the identification, close monitoring and effective management of albuminuria and reduced eGFR.
No takes yet. Share an insight, caveat, or question.
Cunillera et al. (2025) conducted a cohort in Chronic kidney disease (n=438,273). Hypertension and/or type 2 diabetes vs. CKD without hypertension and type 2 diabetes was evaluated on SKI/kidney failure (sHR 1.77, 95% CI 1.65-1.89). Hypertension was associated with an equal or greater risk of CKD progression as type 2 diabetes, with the highest risk of SKI/kidney failure in patients with both.
Synapse has enriched 10 related papers. Consider them for comparative context: